INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
INTEGRA LIFESCIENCES HOLDINGS CORP cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Depreciation and amortization → operating reconciliation: $76,565,000.00Share-based compensation → operating reconciliation: $11,009,000.00Accounts receivable → operating reconciliation: $10,604,000.00Non-cash lease adjustment → operating reconciliation: $2,948,000.00Amortization of debt issuance costs and expenses associated with debt refinancing → operating reconciliation: $2,015,000.00Other non-current liabilities → operating reconciliation: $1,205,000.00Loss on disposal of property and equipment → operating reconciliation: $733,000.00Other non-current assets → operating reconciliation: $389,000.00operating reconciliation → Net cash from operating activities: $32,605,000.00operating reconciliation → Net loss: $134,000.00operating reconciliation → Accounts payable, accrued expenses and other current liabilities: $34,384,000.00operating reconciliation → Prepaid expenses and other current assets: $29,317,000.00operating reconciliation → Inventories: $3,855,000.00operating reconciliation → Deferred income tax provision (benefit): $3,007,000.00operating reconciliation → Contract liabilities: $1,392,000.00operating reconciliation → Change in fair value of contingent consideration and others: $774,000.00Proceeds from borrowings of long-term indebtedness → financing reconciliation: $75,900,000.00Proceeds from exercised stock options and employee stock purchase plan → financing reconciliation: $760,000.00financing reconciliation → Net cash from financing activities: $7,479,000.00financing reconciliation → Payments on debt: $60,475,000.00financing reconciliation → Payments for contingent considerations: $6,842,000.00financing reconciliation → Cash taxes paid in net equity settlement: $1,589,000.00financing reconciliation → Payment of debt issuance costs: $275,000.00Net cash used in investing activities → investing reconciliation: $58,131,000.00investing reconciliation → Purchases of short-term investments: $30,976,000.00investing reconciliation → Purchases of property and equipment: $27,155,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $235,048,000.00Net cash from operating activities → Cash sources and uses: $32,605,000.00Net cash from financing activities → Cash sources and uses: $7,479,000.00Cash sources and uses → Exchange-rate effect: $2,586,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $214,415,000.00Cash sources and uses → Net cash used in investing activities: $58,131,000.00Net loss: -$134,000.00Net loss−$134.00 KDepreciation and amortization: $76,565,000.00Other D&A+$76.57 MDeferred income tax provision (benefit): -$3,007,000.00Deferred income taxes−$3.01 MShare-based compensation: $11,009,000.00Stock-based compensation+$11.01 MAmortization of debt issuance costs and expenses associated with debt refinancing: $2,015,000.00Debt cost & refinancing amort.+$2.02 MNon-cash lease adjustment: $2,948,000.00Non-cash lease adjustment+$2.95 MLoss on disposal of property and equipment: $733,000.00PP&E disposal gain & loss+$733.00 KChange in fair value of contingent consideration and others: -$774,000.00Contingent consideration change−$774.00 KAccounts receivable: $10,604,000.00Accounts receivable+$10.60 MInventories: -$3,855,000.00Inventories−$3.86 MPrepaid expenses and other current assets: -$29,317,000.00Prepaid & other assets−$29.32 MOther non-current assets: $389,000.00Other operating assets+$389.00 KAccounts payable, accrued expenses and other current liabilities: -$34,384,000.00Payables & accrued liabilities−$34.38 MContract liabilities: -$1,392,000.00Deferred revenue−$1.39 MOther non-current liabilities: $1,205,000.00Other noncurrent liabilities+$1.21 MNon-cash impairment charges: $0.00Net cash from operating activities: $32,605,000.00Operating cash+$32.61 Moperating reconciliation: $105,468,000.00Proceeds from borrowings of long-term indebtedness: $75,900,000.00Secured debt issued+$75.90 MPayments on debt: -$60,475,000.00Secured debt repaid−$60.48 MPayments for contingent considerations: -$6,842,000.00Contingent consideration paid−$6.84 MProceeds from exercised stock options and employee stock purchase plan: $760,000.00Stock option & ESPP proceeds+$760.00 KCash taxes paid in net equity settlement: -$1,589,000.00Stock-award tax withholding−$1.59 MPurchases of treasury stock: $0.00Payment of debt issuance costs: -$275,000.00Debt issuance costs−$275.00 KNet cash from financing activities: $7,479,000.00Financing cash+$7.48 Mfinancing reconciliation: $76,660,000.00Purchases of property and equipment: -$27,155,000.00PP&E purchases−$27.16 MPurchases of short-term investments: -$30,976,000.00Investment purchases−$30.98 MNet cash used in investing activities: -$58,131,000.00. Cash required to fund net payments.Investing cash−$58.13 Minvesting reconciliation: $58,131,000.00Cash sources and uses: $275,132,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $235,048,000.00Beginning cash$235.05 MEnding cash: Cash, cash equivalents, and restricted cash: $214,415,000.00Ending cash$214.42 MExchange-rate effect: -$2,586,000.00FX effect−$2.59 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsNet loss −$134.00K + net operating adjustments $32.74M = operating cash +$32.61MFree cash flow$5.45 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change−$20.63 MEnding cash − beginning cash
Chart details

INTEGRA LIFESCIENCES HOLDINGS CORP cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
235,048,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
32,605,000 US dollars. Net cash provided.
Net loss
negative 134,000 US dollars
Depreciation and amortization
76,565,000 US dollars
Deferred income tax provision (benefit)
negative 3,007,000 US dollars
Share-based compensation
11,009,000 US dollars
Amortization of debt issuance costs and expenses associated with debt refinancing
2,015,000 US dollars
Non-cash lease adjustment
2,948,000 US dollars
Loss on disposal of property and equipment
733,000 US dollars
Change in fair value of contingent consideration and others
negative 774,000 US dollars
Accounts receivable
10,604,000 US dollars
Inventories
negative 3,855,000 US dollars
Prepaid expenses and other current assets
negative 29,317,000 US dollars
Other non-current assets
389,000 US dollars
Accounts payable, accrued expenses and other current liabilities
negative 34,384,000 US dollars
Contract liabilities
negative 1,392,000 US dollars
Other non-current liabilities
1,205,000 US dollars
Non-cash impairment charges
0 US dollars
Investing activities
negative 58,131,000 US dollars. Net cash used.
Purchases of property and equipment
negative 27,155,000 US dollars
Purchases of short-term investments
negative 30,976,000 US dollars
Financing activities
7,479,000 US dollars. Net cash provided.
Proceeds from borrowings of long-term indebtedness
75,900,000 US dollars
Payments on debt
negative 60,475,000 US dollars
Payments for contingent considerations
negative 6,842,000 US dollars
Proceeds from exercised stock options and employee stock purchase plan
760,000 US dollars
Cash taxes paid in net equity settlement
negative 1,589,000 US dollars
Purchases of treasury stock
0 US dollars
Payment of debt issuance costs
negative 275,000 US dollars
Operating adjustment reconciliation
105,468,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
76,660,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
58,131,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 2,586,000 US dollars
Ending cash on Jun 30, 2026
214,415,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
275,132,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 20,633,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
32,605,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
27,155,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
5,450,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$134.00K + net operating adjustments $32.74M = operating cash +$32.61M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 32,605,000 US dollars minus 27,155,000 US dollars equals 5,450,000 US dollars.
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!